By SHEILA KAPLAN and DENISE GRADY
The agency reported actions against a biotech company and two large stem cell clinics over unapproved treatments, a move it said was necessary to make way for speedier approval of legitimate therapies.
Published: August 27, 2017 at 08:00PM
from NYT Health http://ift.tt/2wj2NtQ
via IFTTT
from WordPress http://ift.tt/2wNcBzi
via IFTTT
No comments:
Post a Comment